Nicholas Downing - Dec 29, 2023 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Director
Signature
/s/ Nicholas Downing
Stock symbol
NAMS
Transactions as of
Dec 29, 2023
Transactions value $
$0
Form type
3
Date filed
12/29/2023, 05:04 PM

No securities are beneficially owned.